• Home
  • RSS Feeds
  • Blog Archives
Subscribe to Disputing
Book an ADR Service
Call Karl Bayer
Karl Bayer's Disputing Blog - Mediator, Arbitrator, Court Master & Technical Advisor
About Karl  |  Book an ADR Service  |  Contact Karl   (312) 705-9317

Menu 
  • home
  • Mediation
  • Arbitration
  • Court Neutrals
  • Online Dispute Resolution
  • Technology
    • Intellectual Property
    • Privacy and Cybersecurity
    • E-discovery
  • Court Decisions
    • Texas Supreme Court
    • Fifth Circuit
    • Third Court of Appeals
    • U.S. Supreme Court
  • More
    • Legislation
      • Texas
      • United States
    • Healthcare
    • Guest Posts
      • John DeGroote
      • John C. Fleming
      • Rick Freeman
      • Professor Peter Friedman
      • Honorable W. Royal Furgeson, Jr.
      • James M. Gaitis
      • Laura A. Kaster
      • Professor John Lande
      • Philip J. Loree, Jr.
      • Michael McIlwrath
      • F. Peter Phillips
      • Professor Alan Scott Rau
      • Professor Thomas J. Stipanowich
      • Professor S.I. Strong
      • Richard Webb
      • Glen M. Wilkerson
    • International arbitration
    • Regulation
    • Sports and Entertainment


Protecting Trade Secrets Under International Investment Law: What Secrets Investors Should Not Tell States

0
by Beth Graham

Tuesday, Apr 12, 2016


Tweet

Daria Kim, Max Planck Institute for Intellectual Property and Competition Law Research Fellow (2012-2013) and the Chinese University of Hong Kong Faculty of Law Research Associate (2013-2014), has published “Protecting Trade Secrets Under International Investment Law: What Secrets Investors Should Not Tell States,” John Marshall Review of Intellectual Property Law, Vol. 15 (2), 2016.  In her research paper, Ms. Kim addresses whether investor-state arbitration is an effective instrument for protecting pharmaceutical test data and other trade secrets from disclosure by foreign regulatory authorities.

Here is the abstract:

The article addresses specifics of trade secret protection under international investment law. As a particular example, it analyzes protection of pharmaceutical regulatory data against the background of the growing public policy campaign for broader access to clinical trial data and the recent unprecedented practice of the European Medicines Agency of disclosing clinical dossiers submitted for drug marketing approval. Given the significant role of foreign direct investment in the global pharmaceutical industry and substantial, exponentially increasing costs incurred by drug originator companies in conducting clinical trials, the prospect of investor-state dispute over data disclosure does not appear purely hypothetical. The question is whether investor-state arbitration is an apt instrument to protect originators’ data against disclosure by drug regulatory authorities. The analysis suggests that the application of standards of international investment protection depends on the specifics of information at issue, its value, and functions in investors’ commercial operations. With regard to pharmaceutical test data, it is argued that the prospects of investor-state arbitration are rather unfavorable for the investor, when data is disclosed to support policy objectives in public healthcare and medical innovation.

This and other scholarly articles authored by Ms. Kim may be downloaded free of charge from the Social Science Research Network.

Photo credit: Rennett Stowe via Foter.com / CC BY

Related Posts

  • Developing a Framework for Arbitrating Standards-Essential Patent (SEP) DisputesDeveloping a Framework for Arbitrating Standards-Essential Patent (SEP) Disputes
  • Mind the Gap: Bringing Technology to the Mediation TableMind the Gap: Bringing Technology to the Mediation Table
  • Does International Arbitration Enfeeble or Enhance Local Legal Institutions?Does International Arbitration Enfeeble or Enhance Local Legal Institutions?
  • Digital Accessibility and Disability Accommodations in Online Dispute Resolution: ODR for EveryoneDigital Accessibility and Disability Accommodations in Online Dispute Resolution: ODR for Everyone
  • Designing and Implementing a State Court ODR System: From Disappointment to CelebrationDesigning and Implementing a State Court ODR System: From Disappointment to Celebration
  • Collective Redress Arbitration in the European UnionCollective Redress Arbitration in the European Union

Like this article? Share it!


  • Share on LinkedIn (Opens in new window)
    LinkedIn

  • Share on X (Opens in new window)
    X

  • Share on Facebook (Opens in new window)
    Facebook

  • Share on Pinterest (Opens in new window)
    Pinterest

  • Email a link to a friend (Opens in new window)
    Email
About Beth Graham

Beth Graham earned a Master of Arts in Information Science and Learning Technologies from the University of Missouri-Columbia, and a Juris Doctor from the University of Nebraska College of Law, where she was an Eastman Memorial Law Scholar. Beth is licensed to practice law in Texas and the District of Columbia. She is also a member of the Texas Bar College and holds CIPP/US, CIPP/E, and CIPM certifications from the International Association of Privacy Professionals.

Legal Research

Legal Research

Connect with Disputing

Visit Us On LinkedinCheck Our Feed

About Disputing

Disputing is published by Karl Bayer, a dispute resolution expert based in Austin, Texas. Articles published on Disputing aim to provide original insight and commentary around issues related to arbitration, mediation and the alternative dispute resolution industry.

To learn more about Karl and his team, or to schedule a mediation or arbitration with Karl’s live scheduling calendar, visit www.karlbayer.com.

About Disputing

Disputing is published by Karl Bayer, a dispute resolution expert based in Austin, Texas. Articles published on Disputing aim to provide original insight and commentary around issues related to arbitration, mediation and the alternative dispute resolution industry.

To learn more about Karl and his team, or to schedule a mediation or arbitration with Karl’s live scheduling calendar, visit www.karlbayer.com.

Recent Posts

We're Back!!!!
Feb 24, 2025
JAMS Welcomes Karl Bayer to its Panel of Neutrals
JAMS Welcomes Karl Bayer to its Panel of Neutrals
May 28, 2024
Class Action Waivers in Arbitration Agreements: The Twenty-First Century Arbitration Battleground and Implications for the EU Countries
Nov 27, 2023

Featured Posts

Tips on Taking Good Remote Depositions From a Veteran Court Reporter

Online Mediation May Allow Restorative Justice to Continue During COVID-19

Remote Arbitration Best Practices: Witness Examination

Search

Legal Research

Legal Research


© 2026, Karl Bayer. All rights reserved. Privacy Policy